Shengmaisan combined with Liuwei Dihuang Decoction alleviates chronic intermittent hypoxia-induced cognitive impairment by activating the EPO/EPOR/JAK2 signaling pathway

Abstract

Chronic intermittent hypoxia (CIH), a principal pathophysiological aspect of obstructive sleep apnea (OSA), is associated with cognitive deficits. Clinical evidence suggests that a combination of Shengmaisan and Liuwei Dihuang Decoctions (SMS-LD) can enhance cognitive function by nourishing yin and strengthening the kidneys. This study aimed to assess the efficacy and underlying mechanisms of SMS-LD in addressing cognitive impairments induced by CIH. We exposed C57BL/6N mice to CIH for five weeks (20%−5% O₂, 5 min/cycle, 8 h/day) and administered SMS-LD intragastrically (15.0 or 30 g·kg⁻¹·day) 30 min before each CIH session. Additionally, AG490, a JJanus kinase 2 (JAK2) inhibitor, was administered via intracerebroventricular injection. Cognitive function was evaluated using the Morris water maze, while synaptic and mitochondrial structures were examined by transmission electron microscopy. Oxidative stress levels were determined using DHE staining, and the activation of the erythropoietin (ER)/ER receptor (EPOR)/JAK2 signaling pathway was analyzed through immunohistochemistry and Western blotting. To further investigate molecular mechanisms, HT22 cells were treated in vitro with either SMS-LD medicated serum alone or in combination with AG490 and then exposed to CIH for 48 h. Our results indicate that SMS-LD significantly mitigated CIH-induced cognitive impairments in mice. Specifically, SMS-LD treatment enhanced dendritic spine density, ameliorated mitochondrial dysfunction, reduced oxidative stress, and activated the EPO/EPOR/JAK2 signaling pathway. Conversely, AG490 negated SMS-LD’s neuroprotective and cognitive improvement effects under CIH conditions. These findings suggest that SMS-LD’s beneficial impact on cognitive impairment and synaptic and mitochondrial integrity under CIH conditions may predominantly be attributed to the activation of the EPO/EPOR/JAK2 signaling pathway.

Keywords

Chronic intermittent hypoxia / Cognitive impairment / Shengmaisan / Liuwei Dihuang Decoction / Oxidative stress / EPO/EPOR/JAK2 signaling pathway

References

[1] Shen YC, Kung SC, Chang ET, et al. The impact of obesity in cognitive and memory dysfunction in obstructive sleep apnea syndrome[J]. Int J Obes (Lond), 2019, 43(2): 355-361.

[2] Wang B, Li W, Jin H, et al. Curcumin attenuates chronic intermittent hypoxia-induced brain injuries by inhibiting AQP4 and p38 MAPK pathway[J]. Respir Physiol Neurobiol, 2018, 255: 50-57.

[3] Vanek J, Prasko J, Genzor S, et al. Obstructive sleep apnea, depression and cognitive impairment[J]. Sleep Med, 2020, 72: 50-58.

[4] Liu T, Ouyang R. Effect of continuous positive air pressure on cognitive impairment associated with obstructive sleep apnea[J]. J Central South Univ, 2021, 46(8): 865-871.

[5] Seo YJ, Ju HM, Lee SH, et al. Damage of inner ear sensory hair cells via mitochondrial loss in a murine model of sleep apnea with chronic intermittent hypoxia[J]. Sleep, 2017, 40(9): zsx106.

[6] Afsar B, Sag AA, Yalcin CE, et al. Brain-kidney cross-talk: definition and emerging evidence[J]. Eur J Intern Med, 2016, 36: 7-12.

[7] Gao SD, Deng YY, Wang CY, et al. The correlation and clinical significance of Kidney-Cone-Myeloid-Brain in China[J]. J Practical Tradit Chin Internal Medi, 2022, 36(06): 44-47.

[8] Zhao Y, Yang S, Guo Q, et al. Shashen-Maidong Decoction improved chronic intermittent hypoxia-induced cognitive impairment through regulating glutamatergic signaling pathway[J]. J Ethnopharmacol, 2021, 274: 114040.

[9] Tao F, Lu P, Xu C, et al. Metabolomics analysis for defining serum biochemical markers in colorectal cancer patients with Qi deficiency syndrome or Yin deficiency syndrome[J]. Evid Based Complement Alternat Med, 2017, 2017: 7382752.

[10] Chen J, Wang S, Shen J, et al. Analysis of gut microbiota composition in lung adenocarcinoma patients with TCM Qi-Yin deficiency[J]. Am J Chin Med, 2021, 49(7): 1667-1682.

[11] Mo WL, Chai CZ, Kou JP, et al. Sheng-Mai-San attenuates contractile dysfunction and structural damage induced by chronic intermittent hypoxia in mice[J]. Chin J Nat Med, 2015, 13(10): 743-50.

[12] He Q, Zhang QJ. Clinical efficacy of Shengmaisan in the treatment of Qi Yin deficiency syndrome of novel coronavirus pneumonia in convalescent stage[J]. Acta Chin Med Pharm, 2021, 49(03): 84-86.

[13] Lu YL. To explore the curative effect of Shengmaisan Decoction in the treatment of type 2 diabetes with T2DM Qi Yin deficiency syndrome combined with coronary heart disease and angina pectoris[J]. Contemp Med, 2021, 27(33): 131-132.

[14] Liu B, Chen B, Yi J, et al. Liuwei Dihuang Decoction alleviates cognitive dysfunction in mice with D-galactose-induced aging by regulating lipid metabolism and oxidative stress via the microbiota-gut-brain axis[J]. Front Neurosci, 2022, 16: 949298.

[15] Cheng X, Huang Y, Zhang Y, et al. LW-AFC, a new formula from the traditional Chinese medicine Liuwei Dihuang decoction, as a promising therapy for Alzheimer’s disease: pharmacological effects and mechanisms[J]. Adv Pharmacol, 2020, 87: 159-177.

[16] Liu NB, Liu XQ, Liu SC, et al. Study on the effect of Shengmai Yin and Liuwei Dihuang Wan on improving learning and memory disorders induced by chronic stress[J]. Liaoning J Tradit Chin Medi, 2002, (01): 1-3.

[17] Zhang XB, Zeng YM, Zeng HQ, et al. Erythropoietin levels in patients with sleep apnea: a meta-analysis[J]. Eur Arch Otorhinolaryngol, 2017, 274(6): 2505-2512.

[18] Merelli A, Czornyj L, Lazarowski A. Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases[J]. Int J Neurosci, 2015, 125(11): 793-797.

[19] Siren AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress[J]. Proc Natl Acad Sci U S A, 2001, 98(7): 4044-9.

[20] Sun J, Martin JM, Vanderpoel V, et al. The promises and challenges of erythropoietin for treatment of Alzheimer’s disease[J]. Neuromol Med, 2019, 21(1): 12-24.

[21] Wilms H, Schwabedissen B, Sievers J, et al. Erythropoietin does not attenuate cytokine production and inflammation in microglia-implications for the neuroprotective effect of erythropoietin in neurological diseases[J]. J Neuroimmunol, 2009, 212(1-2): 106-11.

[22] Oorschot DE, Sizemore RJ, Amer AR. Treatment of neonatal hypoxic-ischemic encephalopathy with erythropoietin alone, and erythropoietin combined with hypothermia: history, current status, and future research[J]. Int J Mol Sci, 2020, 21(4): 1487.

[23] Tang Q, Ke H, Wu C, et al. Aqueous extract from You-Gui-Yin ameliorates cognitive impairment of chronic renal failure mice through targeting hippocampal CaMKIIalpha/CREB/BDNF and EPO/EPOR pathways[J]. J Ethnopharmacol, 2019, 239: 111925.

[24] Zheng Y, Yang S, Si J, et al. Shashen-Maidong Decoction inhibited cancer growth under intermittent hypoxia conditions by suppressing oxidative stress and inflammation[J]. J Ethnopharmacol, 2022, 299: 115654.

[25] Liu HY, Wu ST. Dosage conversion of classical prescription[J]. Chin J Tradit Chin Med Pharm, 2014, 29(04): 1007-1009.

[26] Nair A, Morsy MA, Jacob S. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development[J]. Drug Dev Res, 2018, 79(8): 373-382.

[27] Yang S, Wen D, Dong M, et al. Effects of cholecystokinin-8 on morphine-induced spatial reference memory impairment in mice[J]. Behav Brain Res, 2013, 256: 346-53.

[28] Gibson BM, Mair R. A pathway for spatial memory encoding[J]. Learn Behav, 2016, 44(2): 97-98.

[29] Payolla TB, Lemes SF, de Fante T, et al. High-fat diet during pregnancy and lactation impairs the cholinergic anti-inflammatory pathway in the liver and white adipose tissue of mouse offspring[J]. Mol Cell Endocrinol, 2016, 422: 192-202.

[30] An JR, Zhao YS, Luo LF, et al. Huperzine A, reduces brain iron overload and alleviates cognitive deficit in mice exposed to chronic intermittent hypoxia[J]. Life Sci, 2020, 250: 117573.

[31] Garbarino S, Scoditti E, Lanteri P, et al. Obstructive sleep apnea with or without excessive daytime sleepiness: clinical and experimental data-driven phenotyping[J]. Front Neurol, 2018, 9: 505.

[32] Andrade AG, Bubu OM, Varga AW, et al. The relationship between obstructive sleep apnea and Alzheimer’s Disease[J]. J Alzheimers Dis, 2018, 64(s1): S255-S270.

[33] Zhang H, Zhou Q, Wang S. Effect of Shengmai Powder and Liuwei Dihuang Pill in the treatment of Type 2 diabetes with deficiency of Qi and Yin[J]. Health Everyone, 2020, (05): 284.

[34] Mei C, Zhang L, Zhang SS. Clinical Study on Shengmai Powder and Liuwei Dihuang Tang for Type 2 Diabetes of Qi-yin Deficiency Type[J]. N Chin Med, 2019, 51(07): 93-96.

[35] Gong LJ, Wang XY, Gu WY, et al. Pinocembrin ameliorates intermittent hypoxia-induced neuroinflammation through BNIP3-dependent mitophagy in a murine model of sleep apnea[J]. J Neuroinflammation, 2020, 17(1): 337.

[36] Dumitrascu R, Heitmann J, Seeger W, et al. Obstructive sleep apnea, oxidative stress and cardiovascular disease: lessons from animal studies[J]. Oxid Med Cell Longev, 2013, 2013: 234631.

[37] Picard M, McEwen BS. Mitochondria impact brain function and cognition[J]. Proc Natl Acad Sci U S A, 2014, 111(1): 7-8.

[38] Jang Y, Lee JH, Lee MJ, et al. Schisandra extract and ascorbic acid synergistically enhance cognition in mice through modulation of mitochondrial respiration[J]. Nutrients, 2020, 12(4): 897.

[39] Nikolaienko O, Patil S, Eriksen MS, et al. Arc protein: a flexible hub for synaptic plasticity and cognition[J]. Semin Cell Dev Biol, 2018, 77: 33-42.

[40] Todorova V, Blokland A. Mitochondria and synaptic plasticity in the mature and aging nervous system[J]. Curr Neuropharmacol, 2017, 15(1): 166-173.

[41] Viviani B, Bartesaghi S, Corsini E, et al. Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor[J]. J Neurochem, 2005, 93(2): 412-421.

[42] Xiong T, Yang X, Qu Y, et al. Erythropoietin induces synaptogenesis and neurite repair after hypoxia ischemia-mediated brain injury in neonatal rats[J]. Neuroreport, 2019, 30(11): 783-789.

[43] Yamada K, Mizuno M, Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory[J]. Life Sci, 2002, 70(7): 735-744.

[44] Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction[J]. Handb Exp Pharmacol, 2014, 220: 223-250.

[45] Castren E, Monteggia LM. Brain-derived neurotrophic factor Signaling in Depression and Antidepressant Action[J]. Biol Psychiatry, 2021, 90(2): 128-136.

[46] Colciaghi F, Nobili P, Cipelletti B, et al. Targeting PSD95-nNOS interaction by Tat-N-dimer peptide during status epilepticus is neuroprotective in MAM-pilocarpine rat model[J]. Neuropharmacology, 2019, 153: 82-97.

[47] Sen T, Gupta R, Kaiser H, et al. Activation of PERK elicits memory impairment through inactivation of CREB and downregulation of PSD95 after traumatic brain injury[J]. J Neurosci, 2017, 37(24): 5900-5911.

[48] Dore K, Malinow R. Elevated PSD-95 blocks ion-flux independent LTD: a potential new role for PSD-95 in synaptic plasticity[J]. Neuroscience, 2021, 456: 43-49.

[49] Jaroudi W, Garami J, Garrido S, et al. Factors underlying cognitive decline in old age and Alzheimer’s disease: the role of the hippocampus[J]. Rev Neurosci, 2017, 28(7): 705-714.

[50] Chandrakantan A, Adler AC, Tohsun M, et al. Intermittent hypoxia and effects on early learning/memory: exploring the hippocampal cellular effects of pediatric obstructive sleep apnea[J]. Anesth Analg, 2021, 133(1): 93-103.

[51] Li W, Yang S, Yu FY, et al. Hydrogen ameliorates chronic intermittent hypoxia-induced neurocognitive impairment via inhibiting oxidative stress[J]. Brain Res Bull, 2018, 143: 225-233.

[52] Xu W, Chi L, Row BW, et al. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea[J]. Neuroscience, 2004, 126(2): 313-23.

[53] Lam CS, Tipoe GL, So KF, et al. Neuroprotective mechanism of Lycium barbarum polysaccharides against hippocampal-dependent spatial memory deficits in a rat model of obstructive sleep apnea[J]. PLoS One, 2015, 10(2): e0117990.

[54] Ma Q. Role of nrf2 in oxidative stress and toxicity[J]. Annu Rev Pharmacol Toxicol, 2013, 53: 401-426.

[55] Lian N, Zhang S, Huang J, et al. Resveratrol attenuates intermittent hypoxia-induced lung injury by activating the Nrf2/ARE pathway[J]. Lung, 2020, 198(2): 323-331.

[56] Kanninen K, Heikkinen R, Malm T, et al. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease[J]. Proc Natl Acad Sci U S A, 2009, 106(38): 16505-16510.

[57] Bhardwaj M, Deshmukh R, Kaundal M, et al. Pharmacological induction of hemeoxygenase-1 activity attenuates intracerebroventricular streptozotocin induced neurocognitive deficit and oxidative stress in rats[J]. Eur J Pharmacol, 2016, 772: 43-50.

[58] Mhillaj E, Catino S, Miceli FM, et al. Ferulic acid improves cognitive skills through the activation of the heme oxygenase system in the rat[J]. Mol Neurobiol, 2018, 55(2): 905-916.

[59] Ali T, Kim T, Rehman SU, et al. Natural dietary supplementation of anthocyanins via PI3K/Akt/Nrf2/HO-1 pathways mitigate oxidative stress, neurodegeneration, and memory impairment in a mouse model of Alzheimer’s disease[J]. Mol Neurobiol, 2018, 55(7): 6076-6093.

[60] Zou Y, Hong B, Fan L, et al. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3beta/Nrf2 signaling pathway[J]. Free Radic Res, 2013, 47(1): 55-63.

[61] Lu R, Kiernan MC, Murray A, et al. Kidney-brain crosstalk in the acute and chronic setting[J]. Nat Rev Nephrol, 2015, 11(12): 707-719.

[62] Kumral A, Tuzun F, Oner MG, et al. Erythropoietin in neonatal brain protection: the past, the present and the future[J]. Brain Dev, 2011, 33(8): 632-643.

[63] Othman M, Rajab E, AlMubarak A, et al. Erythropoietin protects against cognitive impairment and hippocampal neurodegeneration in diabetic mice[J]. Behav Sci (Basel), 2018, 9(1): 4.

[64] Perrone S, Lembo C, Gironi F, et al. Erythropoietin as a neuroprotective drug for newborn infants: ten years after the first use[J]. Antioxidants (Basel), 2022, 11(4): 652.

[65] Nam Y, Joo B, Lee JY, et al. ALWPs improve cognitive function and regulate abeta plaque and tau hyperphosphorylation in a mouse model of Alzheimer’s disease[J]. Front Mol Neurosci, 2019, 12: 192.

[66] Wei M, Feng S, Zhang L, et al. Active fraction combination from Liuwei Dihuang Decoction improves adult hippocampal neurogenesis and neurogenic microenvironment in cranially irradiated mice[J]. Front Pharmacol, 2021, 12: 717719.

[67] Zhang XW, Liu DS, Chen X, et al. Liuwei Dihuang Pills combined with Butylphthalide Capsules for the treatment of cerebral small vessel diseases with non-dementia vascular cognitive impairment[J]. Shanxi Med J, 2020, 49(23): 3198-3200.

[68] Zhang RX, Li MX, Jia ZP. Rehmannia glutinosa: review of botany, chemistry and pharmacology[J]. J Ethnopharmacol, 2008, 117(2): 199-214.

[69] Chen H, Deng C, Meng Z, et al. Effects of Catalpol on Alzheimer’s disease and its mechanisms[J]. Evid Based Complement Alternat Med, 2022, 2022: 2794243.

[70] Dong W, Xian Y, Yuan W, et al. Catalpol stimulates VEGF production via the JAK2/STAT3 pathway to improve angiogenesis in rats’ stroke model[J]. J Ethnopharmacol, 2016, 191: 169-179.

[71] Zhu HF, Wan D, Luo Y, et al. Catalpol increases brain angiogenesis and up-regulates VEGF and EPO in the rat after permanent middle cerebral artery occlusion[J]. Int J Biol Sci, 2010, 6(5): 443-453.

[72] Liu F, Lu Z, Li Z, et al. Electroacupuncture improves cerebral ischemic injury by enhancing the EPO-JAK2-STAT5 pathway in rats[J]. Neuropsychiatr Dis Treat, 2021, 17: 2489-2498.

[73] Liu J, Narasimhan P, Yu F, et al. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin[J]. Stroke, 2005, 36(6): 1264-9.

[74] Dawson TM. Preconditioning-mediated neuroprotection through erythropoietin?[J]. Lancet, 2002, 359(9301): 96-97.

[75] Bolli R, Dawn B, Xuan YT. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury[J]. Trends Cardiovasc Med, 2003, 13(2): 72-79.

[76] Paithankar JG, Saini S, Dwivedi S, et al. Heavy metal associated health hazards: an interplay of oxidative stress and signal transduction[J]. Chemosphere, 2021, 262: 128350.

[77] Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts[J]. Genes Dev, 1999, 13(22): 2905-2927.

[78] Mohi-Ud-Din R, Mir RH, Wani TU, et al. Berberine in the treatment of neurodegenerative diseases and nanotechnology enabled targeted delivery[J]. Comb Chem High Throughput Screen, 2022, 25(4): 616-633.

[79] Yang K, Cao F, Xue Y, et al. Three classes of antioxidant defense systems and the development of postmenopausal osteoporosis[J]. Front Physiol, 2022, 13: 840293.

[80] Molina-Salinas G, Rivero-Segura NA, Cabrera-Reyes EA, et al. Decoding signaling pathways involved in prolactin-induced neuroprotection: A review[J]. Front Neuroendocrinol, 2021, 61: 100913.

[81] Tothova Z, Semelakova M, Solarova Z, et al. The role of PI3K/AKT and MAPK signaling pathways in erythropoietin signalization[J]. Int J Mol Sci, 2021, 22(14): 7682.

Funding

National Natural Science Foundation of China(82274617)

Hebei Natural Science Foundation(H2022423352)

Hebei Natural Science Foundation(H2022423370)

Fundamental Research Funds for the Provisional Universities of Hebei University of Chinese Medicine(YXTD2021005)

Yanzhao Medical Research Project of Hebei University of Chinese Medicine(YZZY2022004)

Graduate Innovation Fund of Hebei University of Chinese Medicine(XCXZZSS2021005)